Experimental evidence that vasoconstriction in hemorrhagic shock does not result in anaerobic metabolism.
D000818:Animals; D001810:Blood Volume; D002245:Carbon Dioxide / Q000378:metabolism; D003201:Computers; D004285:Dogs; D004837:Epinephrine / Q000494:pharmacology; D005947:Glucose / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D007263:Infusions, Parenteral; D007545:Isoproterenol / Q000494:pharmacology; D007773:Lactates / Q000378:metabolism; D008099:Liver / Q000098:blood supply; D008297:Male; D008680:Metaraminol / Q000494:pharmacology; D010101:Oxygen Consumption; D010643:Phenoxybenzamine / Q000494:pharmacology; D012771:Shock, Hemorrhagic / Q000150:complications*; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D007773:Lactates; D014662:Vasoconstrictor Agents; D010643:Phenoxybenzamine; D002245:Carbon Dioxide; D008680:Metaraminol; D005947:Glucose; D007545:Isoproterenol; D004837:Epinephrine